Figure 5
From: Analytical evaluation of circulating tumor DNA sequencing assays
Reproducibility of assays. cfDNA samples with different combinations of cfDNA input and VAF were assayed in duplicate and plasma samples (cfDNA > 50 ng, VAF 0.2%) were assayed in triplicate.
